1. Home
  2. NRDY vs ALDX Comparison

NRDY vs ALDX Comparison

Compare NRDY & ALDX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Nerdy Inc.

NRDY

Nerdy Inc.

HOLD

Current Price

$0.83

Market Cap

114.0M

Sector

Technology

ML Signal

HOLD

Logo Aldeyra Therapeutics Inc.

ALDX

Aldeyra Therapeutics Inc.

HOLD

Current Price

$1.67

Market Cap

124.9M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
NRDY
ALDX
Founded
2007
2004
Country
United States
United States
Employees
N/A
N/A
Industry
Computer Software: Prepackaged Software
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
114.0M
124.9M
IPO Year
2020
2014

Fundamental Metrics

Financial Performance
Metric
NRDY
ALDX
Price
$0.83
$1.67
Analyst Decision
Hold
Buy
Analyst Count
1
2
Target Price
$1.00
$5.50
AVG Volume (30 Days)
938.1K
2.1M
Earning Date
05-07-2026
05-01-2026
Dividend Yield
N/A
N/A
EPS Growth
13.16
40.43
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
$4.88
N/A
Revenue Next Year
$10.03
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.75
$1.07
52 Week High
$1.74
$6.18

Technical Indicators

Market Signals
Indicator
NRDY
ALDX
Relative Strength Index (RSI) 41.34 38.70
Support Level $0.78 $1.49
Resistance Level $1.00 $1.91
Average True Range (ATR) 0.07 0.19
MACD -0.01 -0.06
Stochastic Oscillator 9.04 6.45

Price Performance

Historical Comparison
NRDY
ALDX

About NRDY Nerdy Inc.

Nerdy Inc operate a next-generation live tutoring and intervention platform that leverages the power of human expertise with Developed artificial intelligence (AI) to personalize learning, accelerate student achievement, and empower educators. The company's proprietary platform leverages technology, including AI, to connect learners with instructors across a wide range of subjects and formats, including subscription-based learning, one-on-one instruction, small group tutoring, large-format classes, and assessments. Its flagship business operates under the Varsity Tutors brand. The company's offerings are available directly to students and consumers, as well as through schools and other institutions.

About ALDX Aldeyra Therapeutics Inc.

Aldeyra Therapeutics Inc is a biotechnology company engaged in developing and commercializing next-generation medicines to improve the lives of patients with immune-mediated and metabolic diseases. The company's product candidate, Reproxalap, is a treatment in late-stage development for dry eye disease and allergic conjunctivitis. In addition, it also has additional product candidates in development for proliferative vitreoretinopathy, primary vitreoretinal lymphoma, and other retinal diseases, autoimmune disease, and cancer. Company products includes ADX248, ADX743, ADX631, ADX246, ADX629, ADX2191.

Share on Social Networks: